EDGAR Filing Documents for 0001213900-19-016059

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001213900-19-016059

Filing Date

2019-08-15

Accepted

2019-08-15 16:05:43

Documents

Period of Report

2019-08-14

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO CURRENT REPORT	f8k081419a1_delmarpharma.htm	8-K/A	24938
2	UNDERWRITING AGREEMENT, DATED AS OF AUGUST 14, 2019, BY AND AMONG DELMAR PHARMAC	f8k081419a1ex1-1_delmar.htm	EX-1.1	574992
3	FORM OF COMMON STOCK PURCHASE WARRANT	f8k081419a1ex4-1_delmar.htm	EX-4.1	108988
4	FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT	f8k081419a1ex4-2_delmar.htm	EX-4.2	102035
5	FORM OF UNDERWRITER WARRANT	f8k081419a1ex4-3_delmar.htm	EX-4.3	127752
6	WARRANT AGENCY AGREEMENT, DATED AS OF AUGUST 14, 2019, BY AND BETWEEN DELMAR PHA	f8k081419a1ex4-4_delmar.htm	EX-4.4	306639
7	FORM OF LEAK-OUT AGREEMENT, DATED AS OF AUGUST 14, 2019	f8k081419a1ex10-1_delmar.htm	EX-10.1	20160
8	PRESS RELEASE OF DELMAR PHARMACEUTICALS, INC., DATED AUGUST 14, 2019	f8k081419a1ex99-1_delmar.htm	EX-99.1	10076
9	GRAPHIC	ex99-1_001.jpg	GRAPHIC	15641
	Complete submission text file	0001213900-19-016059.txt		1298444

Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5

Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989

DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)